Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jackie Evans

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The New Zealand Medical Journal|August 30, 2007
PHARMAC responds on Herceptin assumptions and decisionsScott Metcalfe, Jackie Evans
The New Zealand Medical Journal|June 26, 2007
PHARMAC funding of 9-week concurrent trastuzumab (Herceptin) for HER2-positive early breast cancerScott Metcalfe, Jackie Evans, Ginny Priest
The New Zealand Medical Journal|November 1, 2005
PHARMAC responds on long-acting insulin analoguesScott Metcalfe, Jackie Evans, Peter Moodie
Pharmacoeconomics|September 17, 2008
Funding a clinical trial: the perspective of a medicines funderPeter Alsop, Scott Metcalfe, Jackie Evans
The Australian & New Zealand Journal of Obstetrics & Gynaecology|July 2, 2009
Perinatal outcome in fetuses with extremely large nuchal translucency measurementFergus Scott, Jackie Evans, Andrew McLennan
The Queensland Nurse|February 6, 2009
Care with a smileJanet Baillie, Jackie Evans, John Suckling
Seminars in Oncology|October 22, 2018
Response to Cameron et al "Mind the graph" Semin Oncol. 2018George Laking, Jackie Evans, Scott Metcalfe, et al.
Lancet (London, England)|May 20, 2008
Trastuzumab: possible publication biasScott Metcalfe, Carl Burgess, George Laking, et al.
Seminars in Oncology|March 28, 2018
Response to letter to the editor on 'Mind the gap'Scott Metcalfe, Jackie Evans, R Matthew Strother, et al.
Toxicology Mechanisms and Methods|December 22, 2009
The Toxicity of Soman in the African Green Monkey (Chlorocebus aethiops)Kenneth E Despain, John H McDonough, Joseph D McMonagle, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The New Zealand Medical Journal|August 30, 2007
PHARMAC responds on Herceptin assumptions and decisionsScott Metcalfe, Jackie Evans
The New Zealand Medical Journal|June 26, 2007
PHARMAC funding of 9-week concurrent trastuzumab (Herceptin) for HER2-positive early breast cancerScott Metcalfe, Jackie Evans, Ginny Priest
The New Zealand Medical Journal|November 1, 2005
PHARMAC responds on long-acting insulin analoguesScott Metcalfe, Jackie Evans, Peter Moodie
Pharmacoeconomics|September 17, 2008
Funding a clinical trial: the perspective of a medicines funderPeter Alsop, Scott Metcalfe, Jackie Evans
The Australian & New Zealand Journal of Obstetrics & Gynaecology|July 2, 2009
Perinatal outcome in fetuses with extremely large nuchal translucency measurementFergus Scott, Jackie Evans, Andrew McLennan
The Queensland Nurse|February 6, 2009
Care with a smileJanet Baillie, Jackie Evans, John Suckling
Seminars in Oncology|October 22, 2018
Response to Cameron et al "Mind the graph" Semin Oncol. 2018George Laking, Jackie Evans, Scott Metcalfe, et al.
Lancet (London, England)|May 20, 2008
Trastuzumab: possible publication biasScott Metcalfe, Carl Burgess, George Laking, et al.
Seminars in Oncology|March 28, 2018
Response to letter to the editor on 'Mind the gap'Scott Metcalfe, Jackie Evans, R Matthew Strother, et al.
Toxicology Mechanisms and Methods|December 22, 2009
The Toxicity of Soman in the African Green Monkey (Chlorocebus aethiops)Kenneth E Despain, John H McDonough, Joseph D McMonagle, et al.
Pageof 2